| Fri, 23 Jun 2017 15:11:13: | Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
|
| Fri, 23 Jun 2017 14:53:11: | Roche's Ocrevus racks up more positive MS data in relapsing and primary progressive forms
|
| Fri, 23 Jun 2017 14:15:35: | Astellas UK narrowly dodges expulsion after more trouble with Britain's pharma cops
|
| Fri, 23 Jun 2017 13:10:09: | CSL's Haegarda set for Q3 launch as Shire petitions for injunction
|
| Fri, 23 Jun 2017 13:00:11: | FiercePharmaAsia—China’s ICH membership, Takeda’s $111M plant, Ipca ban
|
| Thu, 22 Jun 2017 22:00:13: | FDA rejects Pfizer's Epogen biosimilar for the second time
|
| Thu, 22 Jun 2017 19:02:08: | With GlaxoSmithKline eager for marketing approval, Shingrix passes revaccination test
|
| Thu, 22 Jun 2017 16:43:43: | Vaccines can be deemed defective without scientific proof, EU court rules
|
| Thu, 22 Jun 2017 15:23:14: | Was Bristol-Myers Squibb’s assay to blame for Opdivo’s first-line lung flop?
|
| Thu, 22 Jun 2017 15:04:14: | Mylan shareholders re-elect board but aren't happy with executive pay
|
| Thu, 22 Jun 2017 14:32:09: | GlaxoSmithKline wins $235M from Teva in carve-out patent fight over heart drug
|
| Thu, 22 Jun 2017 13:36:18: | Orphan drug market set to climb above $200B: Report
|
| Thu, 22 Jun 2017 12:45:34: | Russia slashes spending on cancer drugs amid skyrocketing prices: Report
|
| Wed, 21 Jun 2017 17:40:05: | Seqirus first to reach large-scale manufacture of cell-based influenza vaccines
|
| Wed, 21 Jun 2017 14:54:57: | Trump administration's proposal to lower prices might just raise them, critics say
|
| Wed, 21 Jun 2017 14:35:02: | Can Shire's new Mydayis, its latest Adderall iteration, really nab $500M in sales?
|
| Wed, 21 Jun 2017 14:03:52: | McCann Health, celebrating big Lions Health network win, is already prepping for 3-peat
|
| Wed, 21 Jun 2017 13:36:42: | Mylan cut its tax rate into the single digits by investing in coal: Reuters
|
| Wed, 21 Jun 2017 13:23:30: | After Bristol-Myers Squibb's Supreme Court win, Johnson & Johnson seeks relief from $300M in talc verdicts
|
| Wed, 21 Jun 2017 13:11:22: | A lymphoma survivor became a Pfizer scientist. Now she's starring in a TV ad
|
| Wed, 21 Jun 2017 12:04:01: | Talk to the hand in Endo’s new disease awareness TV campaign for Dupuytren's contracture
|
| Tue, 20 Jun 2017 19:24:52: | GlaxoSmithKline's Bexsero, Shingrix to pass $1B sales mark by 2022: report
|
| Tue, 20 Jun 2017 15:17:11: | Neos, facing criticism, wins approval for another easy-to-take pediatric ADHD medication
|
| Tue, 20 Jun 2017 15:04:01: | FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza
|
| Tue, 20 Jun 2017 14:48:40: | Pfizer kicks off human testing with maternal GBS vaccine
|
